Access to anti-retroviral drugs, female in Sierra Leone

Sierra Leone: Access to anti-retroviral drugs, female was 95.0% in 2024. ◆ Volatile

Latest (2024)
95.0%
Change on year
up 8.0%
World rank
19th
of 141 countries
All-time high
95.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Sierra Leone, 2000–2024

0204060801002000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 1 %2006: 1 %2007: 2 %2008: 4 %2009: 7 %2010: 10 %2011: 14 %2012: 16 %2013: 18 %2014: 22 %2015: 26 %2016: 33 %2017: 42 %2018: 48 %2019: 55 %2020: 61 %2021: 74 %2022: 84 %2023: 88 %2024: 95 %

Source: UNAIDS estimates. Measured in %.

Analysis

Sierra Leone recorded 95.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.

That represents a change of up 8.0% on the previous year and up 331.8% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Sierra Leone peaked at 95.0% in 2024 and was at its lowest, 0.0%, in 2000.

Sierra Leone ranks 19th of 141 countries on this measure, in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Sierra Leone, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Sierra Leone, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 1.0%
2006 1.0% +0.0%
2007 2.0% +100.0%
2008 4.0% +100.0%
2009 7.0% +75.0%
2010 10.0% +42.9%
2011 14.0% +40.0%
2012 16.0% +14.3%
2013 18.0% +12.5%
2014 22.0% +22.2%
2015 26.0% +18.2%
2016 33.0% +26.9%
2017 42.0% +27.3%
2018 48.0% +14.3%
2019 55.0% +14.6%
2020 61.0% +10.9%
2021 74.0% +21.3%
2022 84.0% +13.5%
2023 88.0% +4.8%
2024 95.0% +8.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 1.5% 0.0% 7.0% 10
2010s 28.4% 10.0% 55.0% 10
2020s 80.4% 61.0% 95.0% 5

Countries ranked near Sierra Leone

  1. 19 Cameroon 95.0% compare
  2. 19 Tajikistan 95.0% compare
  3. 22 France 93.0% compare
  4. 22 Malawi 93.0% compare
  5. 22 Morocco 93.0% compare

See the full ranking of 160 places →

More gender data for Sierra Leone

All data for Sierra Leone →

Frequently asked questions

What is access to anti-retroviral drugs, female in Sierra Leone?
Access to anti-retroviral drugs, female in Sierra Leone was 95.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Sierra Leone?
The highest recorded value was 95.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Sierra Leone?
The lowest recorded value was 0.0% in 2000.
How does Sierra Leone rank for access to anti-retroviral drugs, female?
Sierra Leone ranks 19th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Sierra Leone?
Over the last ten years it is up 331.8%. The long-run trend across the full record is volatile.
Where does this Sierra Leone data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Sierra Leone. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/sierra-leone/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/sierra-leone/">Access to anti-retroviral drugs, female in Sierra Leone</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.